144P - Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel)
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2019 30 Supplement 5:v45-v45 - Subject
- Language
- ISSN
- 0923-7534